What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.02%Below 5Y avg (1.39%)
Annual Rate
CNY 0.10Paid annual
Payout Ratio
49.5%Sustainable
Last Ex-Dividend
Jun 9, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.98BCNY
295.45M · vs all stocks (USD)
Updated Sep 20, 2026
Trailing P/E
49.20x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Revenue (TTM)
429.73MCNY
64.12M · vs all stocks (USD)
Updated Sep 20, 2026
Profit Margin
9.41%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Beta
0.4360x
vs all stocks
Updated Sep 20, 2026
52-Week Change
-35.09%
vs all stocks
Updated Sep 20, 2026
Market Capitalization
1.98BCNY
295.45M · vs all stocks (USD)
Updated Sep 20, 2026
Enterprise Value
1.67BCNY
248.85M · vs all stocks (USD)
Updated Sep 20, 2026
Trailing P/E
49.20x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Forward P/E
9.74x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Price to Sales (TTM)
4.61x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Price to Book (MRQ)
1.69x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Enterprise to Revenue
3.88x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Enterprise to EBITDA
28.59x
vs Scientific & Technical Instruments peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 13.85×.Updated Sep 20, 2026
Gross Margin
38.59%
vs Scientific & Technical Instruments peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 43.78%.Updated Sep 20, 2026
Profit Margin
9.41%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Operating Margin
4.09%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Return on Assets (TTM)
1.80%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Return on Equity (TTM)
3.63%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Revenue (TTM)
429.73MCNY
64.12M · vs all stocks (USD)
Updated Sep 20, 2026
Revenue per Share (TTM)
2.15CNYUpdated Sep 20, 2026
Quarterly Revenue Growth
-26.40%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Gross Profit (TTM)
188.15MCNY
28.08M · vs all stocks (USD)
Updated Sep 20, 2026
EBITDA (TTM)
120.41MCNY
17.97M · vs all stocks (USD)
Updated Sep 20, 2026
Net Income (TTM)
40.45MCNY
6.04M · vs all stocks (USD)
Updated Sep 20, 2026
Quarterly Earnings Growth (YoY)
-75.40%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Operating Cash Flow (TTM)
154.78MCNY
23.10M · vs all stocks (USD)
Updated Sep 20, 2026
Levered Free Cash Flow (TTM)
110.84MCNY
16.54M · vs all stocks (USD)
Updated Sep 20, 2026
Trailing Annual Dividend Rate
0.1000CNYUpdated Sep 20, 2026
Trailing Annual Dividend Yield
1.02%
vs all stocks
Updated Sep 20, 2026
5-Year Average Dividend Yield
1.39%
vs all stocks
Updated Sep 20, 2026
Payout Ratio
49.50%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Minority Interest (Equity)
7.61MCNYFY2025 · Dec 31, 2025
Revenue
450.49MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
229.34MCNYFY2025 · Dec 31, 2025
Gross Profit
221.16MCNYFY2025 · Dec 31, 2025
Operating Income
90.00MCNY
13.43M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
78.29MCNYFY2025 · Dec 31, 2025
Income Tax Expense
10.76MCNYFY2025 · Dec 31, 2025
Net Income
67.53MCNYFY2025 · Dec 31, 2025
EBIT
78.50MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
120.41MCNYFY2025 · Dec 31, 2025
Research & Development
38.40MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
71.99MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
7.70MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
1.01MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
211.67KCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.3321CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.3321CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
199.37MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
199.37MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
67.53MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-1.32MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
57.95MCNYFY2025 · Dec 31, 2025
Free Cash Flow
25.70MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
120.07MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
67.53MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
329.90KCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-41.31MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
31.40MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-32.25MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-389.00MCNYFY2025 · Dec 31, 2025
Sale of Investments
392.04MCNYFY2025 · Dec 31, 2025
Other Investing Activity
-60.00MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-89.21MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
14.70MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-422.57KCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-18.26MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-701.46KCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-4.68MCNYFY2025 · Dec 31, 2025
Shares Outstanding
201.22MSharesUpdated Sep 20, 2026
Float Shares
74.07MSharesUpdated Sep 20, 2026
% Held by Insiders
62.85%
vs all stocks
Updated Sep 20, 2026
% Held by Institutions
5.16%
vs all stocks
Updated Sep 20, 2026
Total Cash (MRQ)
304.42MCNY
45.43M · vs all stocks (USD)
Updated Sep 20, 2026
Total Cash per Share (MRQ)
1.53CNYUpdated Sep 20, 2026
Total Debt (MRQ)
6.97MCNY
1.04M · vs all stocks (USD)
Updated Sep 20, 2026
Total Debt to Equity (MRQ)
0.0060x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Current Ratio (MRQ)
8.83x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Book Value per Share (MRQ)
5.82CNYUpdated Sep 20, 2026
Total Assets
1.29BCNY
192.76M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
801.49MCNYFY2025 · Dec 31, 2025
Total Liabilities
114.77MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
490.29MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
9.75MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
105.02MCNYFY2025 · Dec 31, 2025
Cash
120.07MCNYFY2025 · Dec 31, 2025
Cash Equivalents
3.75MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
123.82MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
168.60MCNYFY2025 · Dec 31, 2025
Accounts Receivable
286.35MCNYFY2025 · Dec 31, 2025
Inventory
176.56MCNYFY2025 · Dec 31, 2025
Accounts Payable
63.32MCNYFY2025 · Dec 31, 2025
Short-term Debt
14.91MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
1.14MCNYFY2025 · Dec 31, 2025
Long-term Debt
160.11KCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
830.51KCNYFY2025 · Dec 31, 2025
Common Stock (Book)
201.22MCNYFY2025 · Dec 31, 2025
Retained Earnings
746.80MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.18BCNY
175.63M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
11.52MCNYFY2025 · Dec 31, 2025
52-Week Low
8.71CNYUpdated Sep 20, 2026
52-Week High
15.25CNYUpdated Sep 20, 2026
52-Week Change
-35.09%
vs all stocks
Updated Sep 20, 2026
Beta
0.4360x
vs all stocks
Updated Sep 20, 2026
50-Day MA
10.02CNYUpdated Sep 20, 2026
200-Day MA
11.98CNYUpdated Sep 20, 2026
Avg 10-Day Volume
2.99MSharesUpdated Sep 20, 2026
Avg 30-Day Volume
2.65MSharesUpdated Sep 20, 2026
Diluted EPS (TTM)
0.2000CNYUpdated Sep 20, 2026
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 8.83×, higher than 95% of its Scientific & Technical Instruments peers (median 2.38×)Significant
Current ratio: 8.83Industry median: 2.38Industry P95: 7.22Peers compared: 64.00
Debt-to-equity is 0.01×, lower than 95% of its Scientific & Technical Instruments peers (median 0.13×)Notable
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityLow-Leverage Liquidity Configuration
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityLow-Leverage Liquidity Configuration
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityLow-Leverage Liquidity Configuration